Epileptic spasms are a feature of DEPDC5 mTORopathy
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To assess the presence of DEPDC5 mutations in a cohort of patients with epileptic spasms. METHODS: We performed DEPDC5 resequencing in 130 patients with spasms, segregation analysis of variants of interest, and detailed clinical assessment of patients with possibly and likely pathogenic variants. RESULTS: We identified 3 patients with variants in DEPDC5 in the cohort of 130 patients with spasms. We also describe 3 additional patients with DEPDC5 alterations and epileptic spasms: 2 from a previously described family and a third ascertained by clinical testing. Overall, we describe 6 patients from 5 families with spasms and DEPDC5 variants; 2 arose de novo and 3 were familial. Two individuals had focal cortical dysplasia. Clinical outcome was highly variable. CONCLUSIONS: While recent molecular findings in epileptic spasms emphasize the contribution of de novo mutations, we highlight the relevance of inherited mutations in the setting of a family history of focal epilepsies. We also illustrate the utility of clinical diagnostic testing and detailed phenotypic evaluation in characterizing the constellation of phenotypes associated with DEPDC5 alterations. We expand this phenotypic spectrum to include epileptic spasms, aligning DEPDC5 epilepsies more with the recognized features of other mTORopathies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“DEPDC5 pathogenic variants were first reported in familial focal epilepsies 127,128 , and later associated with DEEs 129 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [129]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Berg, A. T., Berkovic, S. F., Brodie, M. J., Buchhalter, J., Cross, J. H., Van Emde Boas, W., Engel, J., French, J., Glauser, T. A., Mathern, G. W., et al. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02522.x · Cited by 4,363 · cited 2×
“We used molecular inversion probes to capture all exons and 5 base pairs of flanking intronic DEPDC5 sequence; next-generation sequencing and data analysis were performed as described previously in 130 patients with epileptic spasms of unknown etiology.(15,18) Known epileptic encephalopathy genes had been excluded in…”
BackgroundMethodSelf-citationDe novo mutations in epileptic encephalopathies
Epi4K Consortium, & Epilepsy Phenome/Genome Project (2013) · Nature · doi:10.1038/nature12439 · Cited by 1,514
Bar-Peled, L., Chantranupong, L., Cherniack, A. D., Chen, W. W., Ottina, K. A., Grabiner, B. C., Spear, E. D., Carter, S. L., Meyerson, M., & Sabatini, D. M. (2013) · Science · doi:10.1126/science.1232044 · Cited by 1,080
Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1
Carvill, G. L., Heavin, S. B., Yendle, S. C., McMahon, J. M., O'Roak, B. J., Cook, J., Khan, A., Dorschner, M. O., Weaver, M., Calvert, S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2646 · Cited by 687
Self-citationMutations in DEPDC5 cause familial focal epilepsy with variable foci
Dibbens, L. M., de Vries, B., Donatello, S., Heron, S. E., Hodgson, B. L., Chintawar, S., Crompton, D. E., Hughes, J. N., Bellows, S. T., Klein, K. M., et al. (2013) · Nature Genetics · doi:10.1038/ng.2599 · Cited by 373 · cited 5×
“This may also be true for several reported missense mutations also present in controls at low frequencies (figure 2).(1,8) It will be important to develop robust functional experiments to assess the pathogenicity of these missense variants in the future.”
BackgroundInfluentialSelf-citationFamilial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations
Baulac, S., Ishida, S., Marsan, E., Miquel, C., Biraben, A., Nguyen, D. K., Nordli, D., Cossette, P., Nguyen, S., Lambrecq, V., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24368 · Cited by 293
D'Gama, A. M., Geng, Y., Couto, J. A., Martin, B., Boyle, E. A., LaCoursiere, C. M., Hossain, A., Hatem, N. E., Barry, B. J., Kwiatkowski, D. J., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24357 · Cited by 290
Mutations of DEPDC5 cause autosomal dominant focal epilepsies
Ishida, S., Picard, F., Rudolf, G., Noé, E., Achaz, G., Thomas, P., Genton, P., Mundwiller, E., Wolff, M., Marescaux, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2601 · Cited by 269 · cited 2×
“Autosomal dominant mutations in DEPDC5 cause familial focal epilepsy with variable foci (FFEVF).(1,2) FFEVF is characterized by seizures arising from different cortical regions in different family members, and onset ranges from infancy to adulthood.”
BackgroundOsborne, J. P., Lux, A. L., Edwards, S. W., Hancock, E., Johnson, A. L., Kennedy, C. R., Newton, R. W., Verity, C. M., & O’Callaghan, F. J. K. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02695.x · Cited by 239
Scheffer, I. E., Heron, S. E., Regan, B. M., Mandelstam, S., Crompton, D. E., Hodgson, B. L., Licchetta, L., Provini, F., Bisulli, F., Vadlamudi, L., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24126 · Cited by 229
Self-citation
Cited by
The landscape of epilepsy-related GATOR1 variants
Baldassari, S., Picard, F., Verbeek, N. E., van Kempen, M., Brilstra, E. H., Lesca, G., Conti, V., Guerrini, R., Bisulli, F., Licchetta, L., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-018-0060-2 · Cited by 240
Review: Mechanistic target of rapamycin (mTOR) pathway, focal cortical dysplasia and epilepsy
Marsan, E., & Baulac, S. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12463 · Cited by 191
Developmental and epileptic encephalopathies
Scheffer, I. E., Zuberi, S., Mefford, H. C., Guerrini, R., & McTague, A. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00546-6 · Cited by 158
Self-citationEpilepsy surgery for patients with genetic refractory epilepsy: a systematic review
Stevelink, R., Sanders, M. W., Tuinman, M. P., Brilstra, E. H., Koeleman, B. P., Jansen, F. E., & Braun, K. P. (2018) · Epileptic Disorders · doi:10.1684/epd.2018.0959 · Cited by 128
Epilepsy in the mTORopathies: opportunities for precision medicine
Moloney, P. B., Cavalleri, G. L., & Delanty, N. (2021) · Brain Communications · doi:10.1093/braincomms/fcab222 · Cited by 125
Metadata
- Authors
- Carvill, G. L., Crompton, D. E., Regan, B. M., McMahon, J. M., Saykally, J., Zemel, M., Schneider, A. L., Dibbens, L., Howell, K. B., Mandelstam, S., Leventer, R. J., Harvey, A. S., Mullen, S. A., Berkovic, S. F., Sullivan, J., Scheffer, I. E., & Mefford, H. C.
- Affiliations
- Royal Children's Hospital (AU)
- Corresponding author
- Scheffer, Ingrid E.
- Mefford, Heather C.
- ORCID
- Venue
- Neurology Genetics
- Published
- 2015-08
- Volume
- 1
- Issue
- 2
- Pages
- e17-e17
- ISSN
- 2376-7839 (ISSN-L)
- PMC
- PMC4807908
- OpenAlex
- W2268666612
- Cited by
- 76
- References
- 24
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 6 · 2023: 10 · 2022: 5 · 2021: 11 · 2020: 6 · 2019: 10 · 2018: 8 · 2017: 5 · 2016: 8 · 2015: 1
- FWCI
- 5.96
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Neurology Genetics (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
- UniSA Research Outputs Repository (University of South Australia) (submittedVersion, other-oa)
- Funders
- U.S. Department of Defense
- Burroughs Wellcome Fund
- Simons Foundation
- American Epilepsy Society
- American Thoracic Society
- Epilepsy Foundation
- Citizens United for Research in Epilepsy
- GlaxoSmithKline
- Sanofi
- American Academy of Neurology
- University of Washington
- International Parkinson and Movement Disorder Society
- Jack Brockhoff Foundation
- Zogenix
- Simons Foundation Autism Research Initiative
- Marinus Pharmaceuticals
- Australian Academy of Science
- University of Melbourne
- Eisai
- Epilepsy Society
- Shepherd Foundation
- National Institutes of Health
- Intellectual and Developmental Disabilities Research Center
- Sanofi China Investment Company
- Medical Research Council
- National Health and Medical Research Council (1068278, 1059666)
- Health Research Council of New Zealand
- National Institute of Neurological Disorders and Stroke (R01NS069605, K99NS089858)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD083091)
- European Maritime and Fisheries Fund
- UCB Pharma
- Cilag
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- DEPDC5, epileptic spasms, mTORopathies, focal cortical dysplasia, de novo mutations, inherited mutations, phenotypic spectrum, focal epilepsy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Epileptic spasms are a feature of DEPDC5 mTORopathy. https://app.cochat.ai/papers/10.1212/nxg.0000000000000016
- The paper
- Carvill, G. L., Crompton, D. E., Regan, B. M., McMahon, J. M., Saykally, J., Zemel, M., Schneider, A. L., Dibbens, L., Howell, K. B., Mandelstam, S., Leventer, R. J., Harvey, A. S., Mullen, S. A., Berkovic, S. F., Sullivan, J., Scheffer, I. E., & Mefford, H. C. (2015). Epileptic spasms are a feature of DEPDC5 mTORopathy. Neurology Genetics. https://doi.org/10.1212/nxg.0000000000000016
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.